CVS Health (CVS)
(Delayed Data from NYSE)
$57.62 USD
+0.73 (1.28%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $57.65 +0.03 (0.05%) 6:28 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
CVS 57.62 +0.73(1.28%)
Will CVS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CVS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CVS
CVS Health (CVS) Falls 24% in 3 Months: Should You Buy the Dip?
CVS Health (CVS) Gains As Market Dips: What You Should Know
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
UnitedHealth (UNH) Stock Drops 8% YTD: Should You Hold or Fold?
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Other News for CVS
CVS Health announces quarterly dividend
CVS Health to hold second quarter 2024 earnings conference call
Walgreens Boots Alliance: Maybe I Was Wrong
UnitedHealth, Humana seen as managed care beneficiaries in second Trump term
RBC says presidential debate bodes well for managed care stocks